Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2024)

Historic Receivables - Other for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q4 2024 value amounting to $2.0 million.

  • Indivior Pharmaceuticals' Receivables - Other rose 10000.0% to $2.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.0 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $2.0 million for FY2024, which is 10000.0% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Receivables - Other of $2.0 million as of Q4 2024, which was up 10000.0% from $1.0 million recorded in Q4 2023.
  • Over the past 5 years, Indivior Pharmaceuticals' Receivables - Other peaked at $2.0 million during Q4 2024, and registered a low of $1.0 million during Q4 2023.